Torii Pharmaceutical Co., Ltd.

Torii Pharmaceutical Co., Ltd.

Share · JP3635800000 (XTKS)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of Torii Pharmaceutical Co., Ltd.
No Price
Share Float & Liquidity
Free Float 3,66 %
Shares Float 1,03 M
Shares Outstanding 28,12 M
Invested Funds

The following funds have invested in Torii Pharmaceutical Co., Ltd.:

Fund
iShares Core MSCI Japan IMI UCITS ETF USD (Dist)
Vol. in million
12,33
Percentage (%)
0,0067 %
Fund
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged (Acc)
Vol. in million
5,04
Percentage (%)
0,0067 %
Company Profile for Torii Pharmaceutical Co., Ltd. Share
Torii Pharmaceutical Co., Ltd. manufactures and markets pharmaceutical products in Japan. It offers therapeutic agents, such as Riona for the treatment of hyperphosphatemia; and REMITCH, an oral therapeutic agent used for the treatment of pruritus in dialysis and liver disease patients. The company also provides ANTEBATE that is used for the treatment of skin diseases, such as atopic dermatitis and contact dermatitis by reducing inflammation; allergen immunotherapy tablets comprising CEDARCURE and MITICURE; and CORECTIM, a topical janus kinase (JAK) inhibitor. It markets its products primarily through medical representatives for medical professionals. The company was formerly known as Torii Shoten K.K and changed its name to Torii Pharmaceutical Co., Ltd. in May 1949. The company was founded in 1872 and is headquartered in Tokyo, Japan. Torii Pharmaceutical Co., Ltd. is a subsidiary of Japan Tobacco Inc.

Company Data

Name Torii Pharmaceutical Co., Ltd.
Company Torii Pharmaceutical Co., Ltd.
Website https://www.torii.co.jp
Primary Exchange XTKS Tokyo
ISIN JP3635800000
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Goichi Matsuda
Market Capitalization 179 Mrd.
Country Japan
Currency JPY
Employees 0,6 T
Address Torii Nihonbashi Bldg., 103-8439 Tokyo
IPO Date 2013-03-15
Dividends from 'Torii Pharmaceutical Co., Ltd.'
Ex-Date Dividend per Share
27.06.2025 0,42 USD
27.12.2024 60,00 JPY
27.06.2024 60,00 JPY
28.12.2023 70,00 JPY
29.06.2023 50,00 JPY
29.12.2022 76,00 JPY
29.06.2022 24,00 JPY
29.12.2021 24,00 JPY
29.06.2021 24,00 JPY
29.12.2020 24,00 JPY

Ticker Symbols

Name Symbol
Over The Counter TRXPF
Tokyo 4551.T
More Shares
Investors who hold Torii Pharmaceutical Co., Ltd. also have the following shares in their portfolio:
iShares Gold EUR Hedged ETF (CH)
iShares Gold EUR Hedged ETF (CH) ETF
JPMORGAN CHASE & CO 4.250% NTS 30/05/28
JPMORGAN CHASE & CO 4.250% NTS 30/05/28 Bond